1. Home
  2. RBBN vs AVIR Comparison

RBBN vs AVIR Comparison

Compare RBBN & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$1.36

Market Cap

355.8M

Sector

Technology

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$4.22

Market Cap

413.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
AVIR
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.8M
413.1M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
RBBN
AVIR
Price
$1.36
$4.22
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$3.30
★ $8.50
AVG Volume (30 Days)
★ 1.3M
277.8K
Earning Date
10-27-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 170.97
3.00
EPS
★ N/A
N/A
Revenue
N/A
★ $351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.15
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.28
$2.87
52 Week High
$3.55
$6.45

Technical Indicators

Market Signals
Indicator
RBBN
AVIR
Relative Strength Index (RSI) 36.16 32.44
Support Level N/A $4.06
Resistance Level $2.11 $4.46
Average True Range (ATR) 0.11 0.25
MACD -0.01 -0.07
Stochastic Oscillator 12.44 20.77

Price Performance

Historical Comparison
RBBN
AVIR

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: